Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
5.045
+0.18
(+3.81%)
USD |
NASDAQ |
Oct 26, 16:00
5.14
+0.10
(+1.88%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Shareholders Equity (Quarterly) : 19.18M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.18M |
| March 31, 2026 | 3.346M |
| December 31, 2025 | 2.254M |
| September 30, 2025 | 1.394M |
| June 30, 2025 | 3.606M |
| March 31, 2025 | 3.285M |
| December 31, 2024 | 0.7092M |
| September 30, 2024 | -1.315M |
| June 30, 2024 | 0.8014M |
| March 31, 2024 | 2.762M |
| Date | Value |
|---|---|
| December 31, 2023 | 4.056M |
| September 30, 2023 | 5.610M |
| June 30, 2023 | 6.936M |
| March 31, 2023 | 6.906M |
| December 31, 2022 | 7.678M |
| September 30, 2022 | 8.405M |
| June 30, 2022 | -2.306M |
| March 31, 2022 | -1.850M |
| December 31, 2021 | -1.628M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.81M |
| Total Liabilities (Quarterly) | 3.629M |
| Debt to Equity Ratio | 0.0102 |
| Current Ratio | 0.1139 |
| Net Debt Paydown Yield | 5.59% |